by Mooslet Writing Services | May 26, 2016 | FDA
Last week, the US Food and Drug Administration (FDA) again delayed making a decision about whether generic drug makers should be required to keep their medication labels updated about newly discovered risks. The delay marked the third time that the FDA has postponed...
by Mooslet Writing Services | Apr 12, 2016 | FDA
If a medical device injures thousands of women and causes hundreds of fetal deaths, how do you think the US Food and Drug Administration (FDA) should react? Most people would answer: take the device off the market until it’s proven to be safer. Unfortunately, that’s...
by Mooslet Writing Services | Mar 31, 2016 | FDA
Are corporations “people” now? Are they entitled to all the same protections that the Bill of Rights confers on individual citizens like you and me? Should the freedom of pharmaceutical marketing be upheld by laws intended for individuals? Big pharma companies, for...
by Mooslet Writing Services | Mar 18, 2016 | FDA
The US Food and Drug Administration (FDA) sent a record low of enforcement letters to big pharma companies in 2015. Are pharmaceutical companies finally following the rules? Or is the FDA playing it fast and loose with regulating big pharma marketing practices? What...
by Chase Sagum | Oct 29, 2015 | FDA
Xarelto: Is Fatal Bleeding as Rare as the FDA Says? More than thirteen million people have been prescribed Xarelto since it was introduced in 2011. Along with Pradaxa and Eliquis, it has quickly replaced Coumadin as one of the most commonly prescribed blood thinners....
Recent Comments